Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway

As an oncogene, MACC1 serves an important function in cancer progression and metastasis. However, the effect of MACC1 in esophageal carcinoma (EC) remains to be fully understood. The present study assessed the association between MACC1 expression and the progression of EC cells. A small interfering...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2017-10, Vol.14 (4), p.4897-4905
Main Authors: Qian, Li-Qiang, Li, Xia-Qin, Ye, Peng-Hui, Su, Hao-Yuan, Wang, Gang, Liu, Yan, Shen, Gen-Hai, Gao, Quan-Gen
Format: Article
Language:English
Subjects:
Apoptosis
Biotechnology
Cancer therapies
Cell adhesion & migration
Colorectal cancer
Esophageal cancer
Fluorides
Immunoglobulins
Kinases
Medical prognosis
Metastasis
Oncology
Phosphatase
Proteins
Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As an oncogene, MACC1 serves an important function in cancer progression and metastasis. However, the effect of MACC1 in esophageal carcinoma (EC) remains to be fully understood. The present study assessed the association between MACC1 expression and the progression of EC cells. A small interfering (si)RNA was delivered into EC cells to downregulate MACC1 expression. The MTT assay demonstrated that EC cell viability was reduced by siRNA-MACC1. Decreasing MACC1 expression increased the apoptotic rate of EC cells compared with control cells. Transwell and Matrigel assays demonstrated that EC cell migration and invasion, respectively, were downregulated by siRNA-MACC1. Furthermore, knocking down MACC1 suppressed the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway by upregulating the expression of phosphatase and tensin homolog (PTEN), a tumor suppressor. The results of the present study revealed that MACC1 expression affected cellular functions of the EC cells through the PTEN/PI3K/Akt signaling pathway. Therefore, MACC1 may potentially serve as a novel biomarker and therapeutic target for EC.
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2017.6790